Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Modulation of Cross-Frequency Theta-Gamma Coupling Via Gamma Transcranial Alternating Current Stimulation in Healthy Adults

NCT07095218 is registered in ClinicalTrials.gov with Medipol University as lead sponsor.

NCT NCT07095218
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07095218 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Modulation of Cross-Frequency Theta-Gamma Coupling Via Gamma Transcranial Alternating Current Stimulation in Healthy Adults
Lead sponsor
Medipol University
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
June 1, 2025
Completion date
May 30, 2027
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healhty